期刊文献+

妊娠对视神经脊髓炎谱系疾病与多发性硬化病程的影响 被引量:4

Influence of pregnancy on the course of neuromyelitis optica spectrum disorders and multiple sclerosis
下载PDF
导出
摘要 目的观察妊娠分娩对视神经脊髓炎谱系疾病(neuromyelitis optica spectrum disorders,NMOSD)与多发性硬化(multiple sclerosis,MS)疾病进程的影响。方法筛选有妊娠史NMOSD患者61例、MS患者68例,回顾性收集其发病年龄、复发次数与时间、妊娠与结局,比较分析NMOSD与MS妊娠期间与产后2年内不同阶段发病与复发情况。结果 (1)NMOSD患者妊娠期疾病发生率高于MS患者(6.56%比0,P=0.047),两者妊娠期复发率(1.45%比1.53%,P=1.000)、产后2年内疾病发生率(31.15%比26.47%;χ~2=0.344,P=0.558)及产后2年内复发率(21.74%比18.77%;χ~2=0.500,P=0.480)比较差异均无统计学意义。(2)NMOSD患者产后≤3个月年均复发率(annualized relapse rate,ARR;以中位数(四分位数间距)表示,下同)最高[4(4)次/年],高于产后3~6个月[0(0)次/年,P=0.015]、12~24个月[0(0)次/年,P=0.006],且产后第1年ARR高于产后第2年ARR[1(0.75)次/年比0(0)次/年,P=0.001],MS患者产后9~12个月ARR显著高于产后6~9个月[(0(4)次/年比0(0)次/年,P=0.005],产后第1年ARR与产后第2年ARR比较差异无统计学意义[1(0)次/年比0(1)次/年,P=0.069]。NMOSD患者产后≤3个月ARR[4(4)次/年比0(4)次/年,P=0.046]与6~9个月ARR[0(0)次/年比0(0)次/年,P=0.042]均高于MS患者。结论 NMOSD患者妊娠期疾病发生率高于MS,产后发生率及复发率均较高,但不同阶段ARR存在统计学差异。 Objective To investigate the effect of pregnancy and delivery/abortion on disease progression of neuromyelitis optica spectrum disorders(NMOSD)and multiple sclerosis(MS).Methods Sixty-one NMOSD patients and sixty-eight MS patients who had histories of pregnancies were selected,and their incidence of pregnancy and outcome,age of onset and relapse frequency were collected retrospectively.The changes of ARR in NMOSD and MS during pregnancy and postpartum were analyzed.Results(1)The proportion of patients with NMOSD onset during pregnancy was higher than that of MS(6.56%vs.0,P=0.047).The proportions of disease relapses during pregnancy(1.45%vs.1.53%,P=1.000),the proportions of disease onset(31.15%vs.26.47%;χ2=0.344,P=0.558)and relapses(21.74%vs.18.77%;χ2=0.500,P=0.480)in 2 years after delivery/abortion between them were not statistically significant.(2)The annualized relapse rate(ARR)during the first 3 months postpartum period of NMOSD[median(interquartile range):4(4)times/year]was higher significantly than ARR during 3-6 months and 12-24 months postpartum periods[0(0)times/year and 0(0)times/year;P=0.015,P=0.006,respectively);and ARR during the first year postpartum period was significantly higher than ARR during the second year postpartum period[1(0.75)times/year vs.0(0)times/year,P=0.001).As to MS,ARR during the 9-12 months postpartum period was higher significantly than ARR during the 6-9 months postpartum period[0(4)times/year vs.0(0)times/year,P=0.005),but ARRs between the first year and second year postpartum period were not different significantly[1(0)times/year vs.0(1)times/year,P=0.069).The ARR of NMOSD patients during 0-3 months and 6-9 months postpartum periods were both significantly higher than that of MS patients[4(4)times/year vs.0(4)times/year,P=0.046;0(0)times/year vs.0(0)times/year,P=0.042).Conclusions Comparing with MS,the disease onset of NMOSD patients were more closely related to pregnancy.Both NMOSD and MS had more onset and relapses after delivery/abortion,and there were significant differences in ARRs at different stages.
作者 仝延萍 杨涛 康越之 程翠翠 王静文 赵天佑 樊永平 TONG Yanping;YANG Tao;KANG Yuezhi;CHENG Cuicui;WANG Jingwen;ZHAO Tianyou;FAN Yongping(Department of Traditional Chinese Medicine,Beijing Tiantan Hospital,Capital Medical University,Beijing 100050,China)
出处 《中国神经免疫学和神经病学杂志》 CAS 北大核心 2018年第1期11-14,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 国家自然科学基金资助项目(81473640 81573898 81173237) 北京中医药科技发展资金项目(JJ2016-11)
关键词 妊娠 视神经脊髓炎谱系疾病 多发性硬化 病程 年复发率 pregnancy neuromyelitis optica spectrum disorders multiple sclerosis disease course annualized relapse rate
  • 相关文献

参考文献2

二级参考文献47

  • 1Gjelsvik B, Rosvold EO, Straand J, et al. Symptom prevalence during menopause and factors associated with symptoms and menopausal age. Results from the Norwegian Hordaland Women's Cohort study. Maturitas, 2011, 70:383-390.
  • 2Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19 731 Norwegian women. Am J Epidemiol, 2003, 157:923-929.
  • 3Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross- sectional survey among midlife Nepalese women. BMC Womens Heahh, 2011, 11:30.
  • 4Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser, 1996, 866: 1-107.
  • 5Soules MR, Sherman S, Pan'ott E, et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med, 2001, 10:843-848.
  • 6Abe T, Bereczki D, Takahashi Y, et al. Medial frontal cortex perfusion abnormalities as evaluated by positron emission tomography in women with climacteric symptoms. Menopause, 2006, 13:891-901.
  • 7Obesity : preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Set, 2000, 894 : i-xii, 1-253.
  • 8Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol, 2001, 153:865-874.
  • 9Castelo-Branco C, Blumel JE, Chedraui P, et al. Age at menopause in Latin America. Menopause, 2006, 13:706-712.
  • 10McKnight KK, Wellons MF, Sites CK, et al. Racial and regional differences in age at menopause in the United States:findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Obstet Gynecol, 2011, 205: 353. e1-8.

共引文献35

同被引文献17

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部